BioMarin
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. The company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline.
BMRN Key Statistics
Stock Snapshot
As of today, BioMarin(BMRN) shares are valued at $59.80. The company's market cap stands at 11.66B, with a P/E ratio of 162.47.
On 2026-09-27, BioMarin(BMRN) stock moved within a range of $59.80 to $61.50. With shares now at $59.80, the stock is trading 0.0% above its intraday low and -2.8% below the session's peak.
Trading activity shows a volume of 1.79M, compared to an average daily volume of 2.07M.
The stock's 52-week range extends from a low of $49.26 to a high of $70.98.
The stock's 52-week range extends from a low of $49.26 to a high of $70.98.
BMRN News
BioMarin Pharmaceutical (NasdaqGS:BMRN) appointed Dr. Robert Plenge to its Board of Directors and Science and Technology Committee. Dr. Plenge joins BioMarin a...
Biomarin Pharmaceutical Inc. (BMRN) announced an update on their ongoing clinical study. The ENERGY 2 study, officially titled “The ENERGY 2 Study: An Open-Lab...
Analyst ratings
77%
of 30 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.